-

Bausch + Lomb Releases 2025 Sustainability Impact Report

The Broader Perspective framework sets direction for long-term environmental and social impact

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the release of its 2025 Sustainability Impact Report, outlining progress against its environmental, social and governance priorities and introducing The Broader Perspective, the company’s sustainability framework designed to guide future action and accountability.

Anchored in the belief that seeing the full picture leads to smarter decisions and greater impact, the new framework highlights how Bausch + Lomb is working across its global operations and value chain to reduce emissions, prevent waste from the start and build sustainable foundations grounded in integrity, safety and respect.

“Sustainability at Bausch + Lomb is about taking a broader perspective, thinking beyond individual roles and working collectively to deliver meaningful impact,” said Al Waterhouse, executive vice president, Supply Chain and Operations, Bausch + Lomb. “Our 2025 Sustainability Impact Report reflects the progress we’re making today, while clearly defining the long-term goals and systems we’re putting in place to support a more sustainable future for our business, our customers and our communities.”

Advancing Toward Net Zero by 2050
The report reaffirms Bausch + Lomb’s global commitment to achieve Net Zero greenhouse gas emissions by 2050 and outlines actions taken in 2025 to strengthen its decarbonization foundation, including:

  • Expanding renewable energy use across multiple global locations and advancing onsite solar installations
  • Developing a Scope 3 greenhouse gas emissions inventory across key categories
  • Establishing an energy reduction playbook to improve energy efficiency at manufacturing sites
  • Identifying primary energy demands for contact lens manufacturing and decreasing power demand for compressed air by 10 percent at the company’s Rochester, New York site

Preventing Waste from the Start
Bausch + Lomb continued to advance circularity and waste reduction initiatives in 2025, focusing on product and packaging design, regulatory readiness and customer engagement by:

  • Advancing packaging reduction and material optimization in response to Extended Producer Responsibility requirements
  • Delivering Biotrue® ONEday daily disposable contact lenses with 50 percent lighter weight plastic and reduced carton size
  • Avoiding approximately 25 tons of paper waste since 2023 by transitioning certain products to electronic Instructions for Use
  • Supporting closed‑loop solutions through programs such as ONE by ONE® and Every Contact Counts recycling programs and the Red Carpet® Repair Service

Building from Integrity and Respect
The report underscores the foundational role of ethics, employee wellbeing and patient safety in Bausch + Lomb’s sustainability journey, highlighting progress including:

  • Registering more than 90% of invited suppliers in the Company’s Vendor Risk Management program
  • Maintaining global certifications across environmental, zero waste, health, safety and energy management systems
  • Supporting access to vision care and community impact programs, including partnerships that benefit Optometry Giving Sight and The Seeing Eye®
  • Advancing innovation in eye health technology, including AI‑enabled diagnostics and new product delivery systems designed to improve patient outcomes

“Our sustainability efforts are grounded in disciplined action and long-term accountability,” said Amy Butler, vice president, Global Environment, Health, Safety and Sustainability, Bausch + Lomb. “By embedding integrity, efficiency and innovation into how we operate every day, we’re building a more resilient company that creates lasting value for customers, partners and communities worldwide.”

The full 2025 Sustainability Impact Report can be found here: https://www.bausch.com/impact/report/.

About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

© 2026 Bausch + Lomb.

Contacts

Media Contact:
Chris Clark
chris.clark@bausch.com
(848) 360-1100

Bausch + Lomb Corporation

NYSE:BLCO

Release Versions

Contacts

Media Contact:
Chris Clark
chris.clark@bausch.com
(848) 360-1100

More News From Bausch + Lomb Corporation

Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that Bausch + Lomb Board of Directors Chairman Thomas J. Appio has been appointed interim chief executive officer, effective immediately. Appio will continue to serve as CEO of Bausch Health while assuming leadership of Bausch + Lomb. Appio was appointed chairman of the Bausch + Lomb Board of Dir...

Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced progress in the development of BL1243 (tonabersat), an investigational oral treatment for dry age-related macular degeneration (AMD), following a constructive meeting with the U.S. Food and Drug Administration (FDA). The discussion provided greater clarity on the clinical development path for BL1243. If successf...

Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 28, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the c...
Back to Newsroom